Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nexgel (NXGL) Operating Leases (2019 - 2025)

Historic Operating Leases for Nexgel (NXGL) over the last 7 years, with Q3 2025 value amounting to $2.3 million.

  • Nexgel's Operating Leases rose 2369.72% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 2369.72%. This contributed to the annual value of $1.5 million for FY2024, which is 1094.38% down from last year.
  • According to the latest figures from Q3 2025, Nexgel's Operating Leases is $2.3 million, which was up 2369.72% from $1.7 million recorded in Q2 2025.
  • In the past 5 years, Nexgel's Operating Leases ranged from a high of $2.3 million in Q3 2025 and a low of $568000.0 during Q1 2021
  • For the 5-year period, Nexgel's Operating Leases averaged around $1.8 million, with its median value being $1.8 million (2021).
  • As far as peak fluctuations go, Nexgel's Operating Leases crashed by 1683.75% in 2021, and later soared by 20052.82% in 2022.
  • Over the past 5 years, Nexgel's Operating Leases (Quarter) stood at $1.7 million in 2021, then fell by 8.66% to $1.6 million in 2022, then rose by 8.41% to $1.7 million in 2023, then dropped by 10.94% to $1.5 million in 2024, then surged by 46.62% to $2.3 million in 2025.
  • Its Operating Leases stands at $2.3 million for Q3 2025, versus $1.7 million for Q2 2025 and $1.7 million for Q1 2025.